The comparative effectiveness of mpMRI and MRI-guided biopsy vs regular biopsy in a population-based PSA testing: a modeling study
Abstract The benefit of prostate cancer screening is counterbalanced by the risk of overdiagnosis and overtreatment. The use of a multi-parametric magnetic resonance imaging (mpMRI) test after a positive prostate-specific antigen (PSA) test followed by magnetic resonance imaging-guided biopsy (MRIGB...
Guardado en:
Autores principales: | Abraham M. Getaneh, Eveline A. M. Heijnsdijk, Harry J. de Koning |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/91d99c51764245b8bc4729d0188fb589 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Performance of prostate health index and PSA density in a diverse biopsy‐naïve cohort with mpMRI for detecting significant prostate cancer
por: Samuel Carbunaru, et al.
Publicado: (2021) -
How to Improve TRUS-Guided Target Biopsy following Prostate MRI
por: Byung Kwan Park
Publicado: (2021) -
Transperineal MRI-US Fusion-Guided Target Biopsy of the Prostate after Abdominoperineal Resection: A Case Report
por: Nando De Vulder, et al.
Publicado: (2021) -
Analysis of risk factors for determining the need for prostate biopsy in patients with negative MRI
por: Linghui Liang, et al.
Publicado: (2021) -
Evaluation of the Predictive Role of Blood-Based Biomarkers in the Context of Suspicious Prostate MRI in Patients Undergoing Prostate Biopsy
por: Pawel Rajwa, et al.
Publicado: (2021)